Tokyo, Japan

Toyokazu Yokomaku



Average Co-Inventor Count = 7.7

ph-index = 4

Forward Citations = 253(Granted Patents)


Location History:

  • Yokomaku, JP (2007)
  • Tokyo, JP (2002 - 2008)

Company Filing History:


Years Active: 2002-2008

Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: Toyokazu Yokomaku: Innovator in Nucleic Acid Analysis

Introduction

Toyokazu Yokomaku is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of nucleic acid analysis, holding a total of 8 patents. His innovative methods have advanced the understanding and application of nucleic acid technologies.

Latest Patents

Yokomaku's latest patents include a method for determining the concentration of target nucleic acid molecules using nucleic acid probes labeled with fluorescent dyes. This method involves providing a nucleic acid probe that reduces fluorescence emission when hybridized with the target nucleic acid. The process includes hybridizing the probe to the target nucleic acid and measuring the decrease in fluorescence emission after hybridization. Another notable patent focuses on monitoring PCR amplification with fluorescently labeled probes or primers, which change fluorescence upon hybridization to a target.

Career Highlights

Throughout his career, Toyokazu Yokomaku has worked with Kankyo Engineering Co., Ltd. His work has been instrumental in developing methods that enhance the accuracy and efficiency of nucleic acid analysis.

Collaborations

Yokomaku has collaborated with notable individuals in his field, including Ryuichiro Kurane and Takahiro Kanagawa. These collaborations have contributed to the advancement of his research and innovations.

Conclusion

Toyokazu Yokomaku is a distinguished inventor whose work in nucleic acid analysis has led to significant advancements in the field. His innovative methods and collaborations continue to influence research and applications in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…